Df Dent & Co Inc
Source: SEC Form 13F · as of Mar 2026Df Dent & Co Inc holds 18 biotech & pharma companies tracked by BioSniper, totaling $270.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$270.2M
| Company | Shares | Value |
|---|---|---|
| TECHBIO-TECHNE Corp | 2,043,047 | $106.8M |
| RGENREPLIGEN CORP | 365,115 | $43.0M |
| MEDPMedpace Holdings Inc. | 74,810 | $35.9M |
| WSTWest Pharmaceutical Services Inc. | 120,597 | $30.2M |
| IDXXIDEXX LABORATORIES INC /DE | 40,023 | $22.5M |
| JNJJOHNSON & JOHNSON | 53,623 | $13.1M |
| ABBVAbbVie Inc. | 25,819 | $5.6M |
| LLYELI LILLY & Co | 3,100 | $2.9M |
| MRKMerck & Co., Inc. | 22,689 | $2.7M |
| ABTABBOTT LABORATORIES | 25,207 | $2.6M |
| PFEPFIZER INC | 43,142 | $1.2M |
| NVSNovartis AG | 5,115 | $781K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,518 | $681K |
| AMGNAMGEN INC | 1,933 | $680K |
| MCKMcKesson Corporation | 578 | $500K |
| PMPhilip Morris International Inc | 2,890 | $478K |
| BMYBRISTOL MYERS SQUIBB CO | 5,110 | $310K |
| NEOGNEOGEN CORP | 22,000 | $204K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.